Yup, AstraZeneca doc statement was future hypothesis I reckon...literally, all the vaccine companies need more time to pass to better understand the results of vaccine trials + real world application. There is no way to know how a vaccine reacts over several years in a person’s body – as there is no lab test tube time bubble method of simulating years of normal living . One of the main reasons why vaccines ‘usually’ take 10-15yrs to release officially. Test A group, check n adjust, test B group, check n adjust, on and on through the alphabet….
No, I don't think every person will get a blood test or repeat vaccines for years - logistically this is impossible to make n deliver to same groups and people tend to get tired of standing in queues over n over. More likely, will continue to test at borders + within communities/population where infection rates spike up etc whilst vaccinating as fast as possible in parallel..and continuing to check if that vaccine works/move over to new vaccine type..
Also from a vaccine standpoint, getting >1-2 boostershots doesn’t make any difference to a host..if anything it means that thevaccine is not working as well in that body for some reason – which willtrigger more study/adjustments if they get enough demographic result…or anothervaccine type will be tested on that demographic to see if it works better.
Companies/govnts will certainly need to continue antigen/antibody tests on large pop groups for reasonable future (24-36mths)....continuing community transmission control VS post-vaccination monitoring & re-infection checks...
- Forums
- ASX - By Stock
- AT1
- AT1 OEM Contracts (various)
AT1 OEM Contracts (various), page-9
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.06M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.2¢ | $2.722K | 119.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22624 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 89366 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22624 | 0.022 |
2 | 147142 | 0.021 |
7 | 857000 | 0.020 |
7 | 800840 | 0.019 |
4 | 262414 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 89366 | 2 |
0.024 | 281206 | 5 |
0.025 | 339000 | 3 |
0.026 | 390045 | 2 |
0.027 | 1093000 | 3 |
Last trade - 15.42pm 20/08/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online